Evaluation of escalating doses of dichloromethotrexate (DCM) with pharmacokinetic analysis in patients with hepatocellular carcinoma and other solid tumors

W. J. Tester, R. C. Donehower, J. L. Eddy

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)C-38
JournalProceedings of the American Society of Clinical Oncology
VolumeVol. 1
StatePublished - 1982

ASJC Scopus subject areas

  • Medicine(all)

Cite this